Table 4. Bivariate and multivariable logistic regression of EORTC QLQ BR23 functional and symptom scales with global health status (QOL) of female breast cancer patients under chemotherapy at TASH Addis Ababa Ethiopia, 2018.
| Variables | Poor QOL N (%) | Good QOL N (%) | COR (95% CI) | AOR (95% CI) | P value | |
|---|---|---|---|---|---|---|
| Functional scale | ||||||
| Body image | Poor | 30 (13.7) | 37 (20.1) | 1 | / | |
| Good | 189 (86.3) | 147 (79.9) | 0.6 (0.37–1.06) | / | ||
| Sexual functioning | Poor | 194 (88.6) | 156 (84.8) | 1 | 1 | |
| Good | 25 (11.4) | 28 (15.2) | 1.4 (1.04–2.48) | 0.7 (0.36–1.65) | 0.504 | |
| Sexual enjoyment | Poor | 4 (11.1) | 10 (25.6) | 1 | / | |
| Good | 32 (88.9) | 29 (74.4) | 0.4 (0.10–1.28) | / | ||
| Future perspective | Poor | 122 (55.7) | 83 (45.1) | 1 | 1 | |
| Good | 97 (44.3) | 101 (54.9) | 1.5 (1.03–2.27) | 1.6 (0.95–2.64) | 0.077 | |
| Symptom scale | ||||||
| Systemic therapy side effects | Poor | 139 (63.5) | 132 (71.7) | 1 | 1 | |
| Good | 80 (36.5) | 52 (28.3) | 0.68 (0.45–0.98) | 1.5 (1.03–7.56) | 0.048* | |
| Breast symptoms | Poor | 193 (88.1) | 170 (92.4) | 1 | / | |
| Good | 26 (11.9) | 14 (7.6) | 0.6 (0.31–1.21) | / | ||
| Arm symptoms | Poor | 47 (21.5) | 21 (11.4) | 1 | 1 | |
| Good | 172 (78.5) | 163 (88.6) | 2.1 (1.22–3.70) | 0.9 (0.46–1.96) | 0.906 | |
| Upset by hair loss | Poor | 54 (27.8) | 38 (23.0) | 1 | / | |
| Good | 140 (72.2) | 127 (77.0) | 1.2 (0.79–2.08) | / | ||
/ indicates: not included in the model
*significant at p<0.05